p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 1-39 (2010)
LAS EPÍFITAS VASCULARES DEL ESTADO DE HIDALGO, MÉXICO: DIVERSIDAD Y DISTRIBUCIÓN
Jacqueline Ceja-Romero, Aniceto Mendoza-Ruiz, Ana Rosa López-Ferrari, Adolfo Espejo-Serna, Blanca Pérez-García y Javier García-Cruz Universidad Autónoma Metropolitana-Iztapalapa, División de…
…
p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 41-101 (2010)
CERATIUM SCHRANK (DINOPHYCEAE) OF THE NATIONAL PARK SISTEMA ARRECIFAL VERACRUZANO, GULF OF MEXICO, WITH A KEY FOR IDENTIFICATION Yuri B. Okolodkov Universidad Veracruzana, Instituto de Ciencias Marinas y Pesquerías, Calle Hidalgo núm. 617, Colonia Río Jamapa, Boca del…
…
p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 103-110 (2010)
PITCAIRNIA YOCUPITZIAE (BROMELIACEAE; PITCAIRNIOIDEAE), NOTABLE NUEVA ESPECIE DE GUERRERO, MÉXICO
Adolfo Espejo-Serna y Ana Rosa López-Ferrari Universidad Autónoma Metropolitana – lztapalapa, División de Ciencias Biológicas y de la Salud, Departamento de Biología,…
…
p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 111-119 (2010)
RESCATE DE EMBRIONES EN HÍBRIDOS INTERGENÉRICOS Helianthus annuus x Tithonia rotundifolia
Martha Gómez-Martínez, M. Humberto Reyes-Valdés*, Juan Manuel Martínez-Reyna, Leticia Escobedo-Bocardo y Hermila T. García-Osuna Universidad Autónoma Agraria Antonio Narro, …
…
p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 121-125 (2010)
SIMSIA BICENTENARIALIS (COMPOSITAE-HELIANTHEAE) UNA ESPECIE NUEVA DEL CENTRO DE MÉXICO*
Jerzy Rzedowski y Graciela Calderón de Rzedowski** Instituto de Ecología, A.C., Centro Regional del Bajío, Apdo. postal 386, 61600 Pátzcuaro, Michoacán, México RESUMEN Se describe…
…
p { margin-bottom: 0.08in; } Acta Botanica Mexicana 93: 127-143 (2010)
CUATRO NUEVAS ESPECIES DE VERBESINA (COMPOSITAE: HELIANTHEAE) DEL CENTRO DE MÉXICO
Pablo Carrillo-Reyes, Jerzy Rzedowski y Graciela Calderón de Rzedowski Instituto de Ecología, A.C., Centro Regional del Bajío, Apdo. postal 386, 61600 Pátzcuaro, Michoacán, México. …
…
Publication year: 2010
Source: The American Journal of Geriatric Pharmacotherapy, Volume 8, Issue 4, August 2010, Page 293
Jack J., Chen
Publication year: 2010
Source: The American Journal of Geriatric Pharmacotherapy, Volume 8, Issue 4, August 2010, Pages 294-315
Lindy D., Wood , Joshua J., Neumiller , Stephen M., Setter , Erin K., Dobbins
Background: Parkinson’s disease (PD) is associated with a host of nonmotor symptoms, including psychosis, cognitive impairment, depression, sleep disturbance, swallowing disorders, gastrointestinal symptoms, and autonomic dysfunction. The nonmotor symptoms of PD have the potential to be more debilitating than the motor features of the disorder.Objective: The aim of this article was to review treatment options for the nonmotor manifestations of PD, including pharmacologic and nonpharmacologic interventions.Methods: The PubMed and MEDLINE databases were searched for articles published in English between January 1966 and April 2010, using the terms Parkinson’s disease, nonmotor, psychosis, hallucination, antipsychotic, cognitive impairment, dementia, depression, sleep disturbance, sleepiness,…
Publication year: 2010
Source: The American Journal of Geriatric Pharmacotherapy, Volume 8, Issue 4, August 2010, Pages 316-330
Marty L., Eng , Timothy E., Welty
Background: Hallucinations and psychosis are common in patients with Parkinson’s disease (PD), with reported prevalences of up to 48% and 80%, respectively. However, few randomized, double-blind, placebo-controlled trials evaluating the treatment options have appeared in the literature. The studies that have been published were complicated by lack of agreement on the diagnosis of psychosis in PD, poor completion rates, mixed populations that included dementia, and other issues. Several reviews, guidelines, and consensus statements have sought to establish standards for treating these symptoms of PD. In 2006, the American Academy of Neurology (AAN) published a practice guideline (based on articles published…
Publication year: 2010
Source: The American Journal of Geriatric Pharmacotherapy, Volume 8, Issue 4, August 2010, Pages 331-373
David R.P., Guay
Background: Few drugs are available for the management of hyperkinetic movement disorders such as the dystonias, choreas, dyskinesias, and tics. Those that are available (primarily neuroleptics) are associated with a wide range of potentially serious adverse effects, including induction of tardive movement disorders. Tetrabenazine (TBZ) is a monoamine-depleting agent initially studied in the 1950s and currently approved by the US Food and Drug Administration for the treatment of chorea in Huntington’s disease.Objective: This article reviews the chemistry, pharmacology, pharmacokinetics, therapeutic use, tolerability, drug-interaction potential, and dosing and administration of TBZ.Methods: MEDLINE was searched (1950–February 2010) for English-language articles investigating any…